Eli Lilly & Co.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
/ 
Eli Lilly and Co. (LLY) is a US-based pharmaceutical company that develops, manufactures, and markets medicines in key therapeutic areas, including diabetes, oncology, immunology, neuroscience, and obesity. Founded in 1876 and headquartered in Indianapolis, Indiana, the company is one of the largest pharmaceutical groups globally.
Its product portfolio includes widely prescribed treatments for diabetes and obesity, such as insulin products and incretin-based therapies, as well as innovative medicines for cancer and autoimmune diseases. Lilly has also advanced research in Alzheimer's disease and other central nervous system conditions.
The company invests heavily in research and development, maintaining laboratories and clinical programmes worldwide. It distributes its medicines in more than 100 countries, supported by a broad network of partnerships with research institutions and healthcare providers.
Eli Lilly and Co. is listed on the New York Stock Exchange (NYSE).
Saxo provides this content for general information only. It is not intended as personal advice, an offer, or a recommendation. Saxo does not guarantee accuracy or completeness and accepts no liability for losses. Consider obtaining independent advice before any investment decision.
Others were interested in
See all stocksFrequently asked questions
To buy Eli Lilly & Co. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Eli Lilly & Co. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Eli Lilly & Co. is LLY:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Eli Lilly & Co. has its primary listing on New York Stock Exchange. You can trade Eli Lilly & Co. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Eli Lilly & Co. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Eli Lilly & Co. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Eli Lilly & Co..